BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 19250736)

  • 1. Co-localization of tryptase and cathepsin-G in mast cells in cutaneous mastocytosis.
    Ribatti D; Nico B; Finato N; Crivellato E; Beltrami CA
    Cancer Lett; 2009 Jul; 279(2):209-12. PubMed ID: 19250736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of MC(T) and MC(TC) mast cells in tissue.
    Schwartz LB
    Methods Mol Biol; 2006; 315():53-62. PubMed ID: 16110148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
    Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M
    Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
    Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
    Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell numbers and protease expression patterns in biopsy specimens following renal transplantation from living-related donors predict long-term graft function.
    Ishida T; Hyodo Y; Ishimura T; Takeda M; Hara I; Fujisawa M
    Clin Transplant; 2005 Dec; 19(6):817-24. PubMed ID: 16313331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
    Sundram UN; Natkunam Y
    J Cutan Pathol; 2007 Apr; 34(4):289-95. PubMed ID: 17381798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptase- and leptin-positive mast cells correlate with vascular density in uterine leiomyomas.
    Ribatti D; Belloni AS; Nico B; Salà G; Longo V; Mangieri D; Crivellato E; Nussdorfer GG
    Am J Obstet Gynecol; 2007 May; 196(5):470.e1-7. PubMed ID: 17466707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing human heart.
    Jahanyar J; Youker KA; Loebe M; Assad-Kottner C; Koerner MM; Torre-Amione G; Noon GP
    J Surg Res; 2007 Jun; 140(2):199-203. PubMed ID: 17418861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy.
    Samorapoompichit P; Schernthaner GH; Worda C; Wimazal F; Krauth MT; Sperr WR; Valent P
    Histopathology; 2006 Feb; 48(3):247-57. PubMed ID: 16430471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of tryptase-positive and bikunin-negative mast cells in psoriatic skin lesions.
    Ashenagar MS; Sugihara K; Maeda A; Isogai R; Takahashi M; Aisu K; Horiuchi A; Aragane Y; Kawada A; Tezuka T
    Arch Dermatol Res; 2007 Feb; 298(9):421-6. PubMed ID: 17146627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide blood levels correlate with mast cell load in patients with mastocytosis.
    Maintz L; Wardelmann E; Walgenbach K; Fimmers R; Bieber T; Raap U; Novak N
    Allergy; 2011 Jul; 66(7):862-9. PubMed ID: 21284654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
    Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous labeling of mast cell proteases and protease mRNAs at the bone-implant interface of aseptically loosened hip implants.
    Qiu J; Beckman MJ; Qian J; Jiranek W
    J Orthop Res; 2005 Jul; 23(4):942-8. PubMed ID: 15972256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
    Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
    Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
    Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study.
    Horny HP; Greschniok A; Jordan JH; Menke DM; Valent P
    J Clin Pathol; 2003 Feb; 56(2):103-6. PubMed ID: 12560387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of novel tissue microarrays to investigate expression of tryptase, chymase and KIT protein in placental mast cells.
    Noack F; Krüger S; Thorns C; Finas D; Stöcker W; Diedrich K; Horny HP
    Arch Gynecol Obstet; 2005 Sep; 272(3):223-8. PubMed ID: 16142475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.